Antibacterial effects of sol-gel-derived bioactive glass nanoparticle on aerobic bacteria

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 1, 2010, Pages 160-168

  Mortazavi, V ^a   Mehdikhani Nahrkhalaji, M ^b   Fathi, M H ^b   Mousavi, S B ^a   Nasr Esfahani, B ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aerobic bacteria; Antibacterial activity; Bioactive glass; Nanoparticles; Sol gel processes

Indexed keywords

AEROBIC BACTERIUM; AMORPHOUS STRUCTURES; ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL EFFECTS; BACTERIOSTATIC; BONE DEFECT; CELL LINES; CHARACTERIZATION TECHNIQUES; CHEMICAL COMPOSITIONS; E. COLI; MOUSE-FIBROBLASTS; NANO POWDERS; P.AERUGINOSA; PSEUDOMONAS AERUGINOSA; ROOT CANALS; S. AUREUS; SALMONELLA TYPHI; SOL-GEL TECHNIQUE; STAPHYLOCOCCUS AUREUS; TEM;

BACTERIA; BACTERIOLOGY; CELL CULTURE; CONCENTRATION (PROCESS); DENTAL EQUIPMENT; ESCHERICHIA COLI; GELS; NANOPARTICLES; NANOSTRUCTURED MATERIALS; SCANNING ELECTRON MICROSCOPY; SOL-GEL PROCESS; SOL-GELS; SOLS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

BIOACTIVE GLASS;

BIOACTIVE GLASS NANOPOWDER; GELATIN; GLASS; NANOPARTICLE; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELL STRAIN L 929; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; GEL; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY FLUORESCENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA, AEROBIC; BIOCOMPATIBLE MATERIALS; GLASS; MATERIALS TESTING; MICE; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; PARTICLE SIZE; POWDERS; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 77952688574     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32678     Document Type: Article

References (38)

1. Schierholz JM, Beuth J. Implant infections: a haven for opportunistic bacteria. J Hosp Infect 2001;49:87-93. (Pubitemid 32982681)
2. Green SA. Complications of external skeletal fixation. Clin Orthop and Rel Res 1983;180:109-116.
3. Ahlborg HG, Josefsson PO. Pin-tract complications in external fixation of fractures of the distal radius. Acta Orthop Scand 1999;70:116-118. (Pubitemid 29221712)
4. Garberina MJ, Fitchn RD, Hoffmann ED, Hardaker WT, Vail TP, Scully SP. Knee arthrodesis with circular external fixation. Clin Orthop and Rel Res 2001;382:168-178. (Pubitemid 32047443)
5. Hebert CK, Williams RE, Levy RS, Barrack RL. Cost of treating an infected total knee replacement. Clin Orthop and Rel Res 1996;331:140-145. (Pubitemid 26357698)
6. Ostermann PAW, Henry SL, Seligson D. The role of local antibiotic therapy in the management of compound fractures. Clin Orthop Rel Res 1993;295:102-111. (Pubitemid 23299636)
7. Ostermann PAW, Henry SL, Seligson D. Timing of wound closure in severe compound fractures. Orthopedics 1994;17:397-399. (Pubitemid 24145491)
8. Shors EC. Coralline bone graft substitutes. Orthop Clin N Am 1999;30:599-613.
9. Chapman MW. Bone grafting. In: Chapman MW, Madison M, editors. Operative Orthopedics. Philadelphia: JB Lippincott; 1993. p 139-149.
10. Lane JM, Tomin E, Bostrom MPG. Biosynthetic bone grafting. Clin Orthop 1999;367S:107-117.
11. Rikli DA, Regazzoni P, Perren SM. Is there a need for resorbable implants or bone substitutes? Injury 2002;33(Suppl 2):2-3.
12. Allan I, Newman H, Wilson M. Particulate bioglass® reduces the viability of bacterial biofilms formed on its surface in an in vitro model. Clin Oral Impl Res 2002;13:53-58. (Pubitemid 41719939)
13. Hench LL. Bioceramics. J Am Ceram Soc 1998;81:1705-1728.
14. Kokubo T. Novel bioactive materials. An Quim Int Ed 1997;93:S49-S55.
15. Hench LL, Kokubo T. Properties of bioactive glasses and glass-ceramics. In: Black J, Hastings G, editors. Handbook of Biomaterial Properties. London: Chapman & Hall; 1998. p 355.
16. Vallet- Regi M, Ragel CV, Salinas AJ. Glasses with medical applications. Eur J Inorg Chem 2003;6:1029-1042.
17. Xynos ID, Hukkanen MVJ, Buttery LDK, Hench LL, Polak JM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
18. Wheeler DL, Montfort MJ, McLoughlin SW. Differential healing response of bone adjacent to porous implants coated with hydroxyapatite and 45S5 bioactive glass. J Biomed Mater Res A 2001;55:603-612.
19. Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin- like growth factor II mRNA expression and protein synthesis. Biochem Bioph Res Co 2000;276:461-465.
20. Effah Kaufmann EA, Ducheyne P, Shapiro IM. Evaluation of osteoblast response to porous bioactive glass (45S5) substrates by RT-PCR analysis. Tissue Eng 2000;6:19-28. (Pubitemid 30123979)
21. Bosetti M, Hench LL, Zanardi L, Cannas M. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res 2003;64:189-195. (Pubitemid 37521483)
22. Schepers E, Barbier L, Ducheyne R. Implant placement enhanced by bioactive glass particles of narrow size range. Int J Oral Max Impl 1998;13:655-665. (Pubitemid 128505857)
23. Stoor P, Soderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand 1998;56:161-165. (Pubitemid 28330891)
24. Allan I, Newman H, Wilson M. Antibacterial activity of particulate Bioglass® against supra- and subgingival bacteria. Biomaterials 2001;22:1683-1687. (Pubitemid 32551920)
25. Munukka E, Lepparanta O, Korkeamaki M, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylanen H, Salonen JI, Viljanen MK. Eerola E. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med 2008;19:27-32.
26. Waltimo T, Brunner TJ, Vollenweider M, Stark WJ, Zehnder M. Antimicrobial effect of nanometric Bioactive Glass 45S5. J Dent Res 2007;86:754-757.
27. Balamurugan A, Balossier G, Laurent-Maquin D, Pina S, Rebelo AHS, Faure J, Ferreira JMF. An in vitro biological and anti-bacterial study on a sol-gel derived silver-incorporated bioglass system. Dent Mater 2008;24:1343-1351.
28. Hench LL, West JK. The sol-gel process. Chem Rev 1990; 90:33-72.
29. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000;21:1803-1810. (Pubitemid 30365044)
30. Webster TJ, Siegel RW, Bizios R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999;20:1221-1227.
31. Lepparanta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, Ylanen H, Salonen JI, Viljanen MK, Eerola E. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci: Mater Med 2008; 19:547-551.
32. Panyala NR, Mendez EMP, Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human health. J Appl Biomed 2008;6:117-129.
33. Campoccia D, Montanaro L, Arciola CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006;27:2331-2339.
34. Waltimo T, Brunner TJ, Vollenweider M, Stark WJ, Zehnder M. Antimicrobial effect of nanometric bioactive glass 45S5. J Dent Res 2007;86:754-757.
35. Valerio P, Pereira MM, Goes AM, Leite MF. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004;25: 2941-2948.
36. Bosetti M, Cannas M. The effect of bioactive glasses on bone marrow stromal cells differentiation. Biomaterials 2005;26: 3873-3879.
37. Carlisle EM. In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr 1976;106:478-484.
38. Zhong I, Greenspan DC. Bioactive sol-gel compositions and methods. United States Patent US6171986B1. 2001.